FDA Commissioner Scott Gottlieb’s Speech on Biosimilars

In a speech at conference sponsored by America’s Health Insurance Plans, the trade association of private insurance companies, FDA Commissioner Scott Gottlieb called for greater education efforts about biosimilars and discussed the hurdles to biosimilars getting into patients’ hands. According to MedPage Today, pointed fingers at insurers and manufacturers for problems confronting biosimilars’ success.
“Patient access to these innovations will depend on reforms,” Gottlieb said, encouraging parties in American healthcare “to deliver the best medical outcomes … doing this with the long run in mind and patients at the heart of what we do.”
Read about Commissioner Gottlieb’s speech in Medpage Today.

Become a Member

Whether you have an established practice, you’re fresh out of your fellowship, or you’re a hospital-based rheumatologist considering private practice, United Rheumatology offers the resources and services you need to advance your career and your clinic.


Find a UR Rheumatologist Near Me

© 2023 United Rheumatology